STAT3 and myocarditis: These data illustrated that downregulation of activated STAT3 can significantly aggravate the severity of CVB3-induced myocarditis, eliminating the therapeutic effect of dapagliflozin, which indicates that dapagliflozin alleviate myocarditis through activating stat3 signal pathway.